Doctronic | Series BMar 2026$40M Series ASep 2025$20M | $60M |
| Co-investors: Faraz Fatemi (Lightspeed Venture Partners), Scott Belsky (A24), Fei-Fei Li (AI4ALL) |
Gyde | Series AJan 2026$60M | $60M |
| Co-investors: Ludwig Schulze (Alumni Ventures ), Vaibhav Domkundwar (Better Capital) |
Assort Health | Series BOct 2025$76M | $220M |
| Co-investors: Joe Montana (Liquid 2 Ventures), Kristina Shen (Andreessen Horowitz), Galym Imanbayev (Lightspeed Venture Partners), Matt Murphy (Menlo Ventures), Bill Trenchard (First Round Capital), Matt Humphrey (Quiet Capital), Immad Akhund (Y Combinator) |
Thyme Care | Series DSep 2025$97M Series CJul 2024$55M Series BAug 2023$60M Series AOct 2021$22M | $230M |
| Co-investors: Vineeta Agarwala (Andreessen Horowitz), Kurt Sheline (Echo Health Ventures), Vivek Garipalli (Wormhole Capital), David Whelan (Town Hall Ventures), Vijay Patel (CVS Health Ventures), Faraz Rahman (CVS Health Ventures) |
Odyssey Therapeutics | Series DSep 2025$210M | $700M |
| Co-investors: Elena Viboch (General Catalyst), Ravi Mhatre (Lightspeed Venture Partners), Jonathan MacQuitty (Lightspeed Venture Partners), Lorence Kim (Third Rock Ventures), Carl Gordon (OrbiMed Advisors), Jill carroll (SR One), Nan Li (6 Dimensions Capital) |
Tennr | Series CJun 2025$100M | $160M |
| Co-investors: Kristina Shen (Andreessen Horowitz), Galym Imanbayev (Lightspeed Venture Partners), Guru Chahal (Lightspeed Venture Partners), Zeya Yang (Andreessen Horowitz), Somesh Dash (IVP), Joanne Chen (Foundation Capital), Jennifer Kaehms (Foundation Capital), Allison Pickens (Allison Pickens Ventures, formerly The New Normal Fund), Warrick Shanly (Soma Capital), Alex Kayyal (Salesforce Ventures) |
Neuralink | Series EMay 2025$650M | $1.2B |
| Co-investors: David Krane (GV (Google Ventures)), Andrew Reed (Sequoia Capital), Ravi Mhatre (Lightspeed Venture Partners), Jonathan MacQuitty (Lightspeed Venture Partners), Peter Thiel (Founders Fund), Fred Ehrsam (Paradigm), Michael Mignano (Lightspeed Venture Partners), Krishna Yeshwant (GV (Google Ventures)), Shaun Maguire (Sequoia Capital), Robert Nelsen (ARCH Venture Partners), Bryan Rosenblatt (Craft Ventures), Ken Howery (Unknown Ventures), Blake Byers (NewLimit), Bill Lee (Craft Ventures), Sam Altman, Shane Neman |
Antares Therapeutics | Series AMay 2025$180M | $180M |
| Co-investors: Ravi Mhatre (Lightspeed Venture Partners), Jonathan MacQuitty (Lightspeed Venture Partners), Jean-François Formela (Atlas Venture) |